92 related articles for article (PubMed ID: 2764976)
1. Tumor size-dependent elevations of serum gangliosides in patients with head and neck carcinomas.
Portoukalian J; David MJ; Shen X; Richard M; Dubreuil C
Biochem Int; 1989 Apr; 18(4):759-65. PubMed ID: 2764976
[TBL] [Abstract][Full Text] [Related]
2. [A new marker in oncology. Assay of gangliosides bound to sialic acid].
Pignat JC; Portoukalian M; Poupart M; Haguenauer JP; Richard M
Ann Otolaryngol Chir Cervicofac; 1989; 106(8):547-9. PubMed ID: 2619157
[TBL] [Abstract][Full Text] [Related]
3. Serum sialic acid forms as markers for head and neck malignancies.
Bhatavdekar JM; Vora HH; Patel DD
Neoplasma; 1988; 35(4):425-34. PubMed ID: 3185839
[TBL] [Abstract][Full Text] [Related]
4. [N-acetylneuraminic acid (sialic acid) as a tumor marker in head and neck cancers].
Fischer F; Egg G
HNO; 1990 Oct; 38(10):361-3. PubMed ID: 2283329
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of glycoproteins as prognosticators in head and neck malignancy.
Bathi RJ; Nandimath K; Kannan N; Shetty P
Indian J Dent Res; 2001; 12(2):93-9. PubMed ID: 11665403
[TBL] [Abstract][Full Text] [Related]
6. Expression of GD3 ganglioside in childhood T-cell lymphoblastic malignancies.
Merritt WD; Casper JT; Lauer SJ; Reaman GH
Cancer Res; 1987 Mar; 47(6):1724-30. PubMed ID: 3493067
[TBL] [Abstract][Full Text] [Related]
7. Serum gangliosides in cerebral astrocytoma.
Lo HS; Hogan EL; Koontz DA; Traylor TD
Ann Neurol; 1980 Nov; 8(5):534-8. PubMed ID: 7436395
[TBL] [Abstract][Full Text] [Related]
8. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck.
Inal E; Laçin M; Asal K; Ceylan A; Köybaşioğlu A; Ileri F; Uslu SS
Kulak Burun Bogaz Ihtis Derg; 2004; 12(1-2):23-30. PubMed ID: 16010093
[TBL] [Abstract][Full Text] [Related]
9. The significance of Tenascin-C serum level as tumor marker in squamous cell carcinoma of the head and neck.
Pauli C; Stieber P; Schmitt UM; Andratschke M; Hoffmann K; Wollenberg B
Anticancer Res; 2002; 22(5):3093-7. PubMed ID: 12530049
[TBL] [Abstract][Full Text] [Related]
10. [Sialic acid in the serum--an indicator for malignant growth?].
Schulze G
Arch Geschwulstforsch; 1990; 60(1):19-24. PubMed ID: 2310297
[TBL] [Abstract][Full Text] [Related]
11. Abnormality of gangliosides in erythrocyte membranes of schizophrenic patients.
Haselhorst U; Schenk H; Beyer I; Uebelhack R; Franke E; Kielstein V
Clin Physiol Biochem; 1988; 6(5):281-4. PubMed ID: 3229070
[TBL] [Abstract][Full Text] [Related]
12. [Usefulness of sialic acid as a tumor marker].
Feliú J; Daimiel E; Vicente J; Martín G; García Girón C; Chacón I; González Barón M
Rev Clin Esp; 1989 May; 184(8):401-3. PubMed ID: 2781072
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of soluble adhesion molecules CD44 (CD44st, CD44v5, CD44v6), ICAM-1, and VCAM-1 as tumor markers in head and neck cancer.
Kawano T; Yanoma S; Nakamura Y; Shiono O; Kokatu T; Kubota A; Furukawa M; Tsukuda M
Am J Otolaryngol; 2005; 26(5):308-13. PubMed ID: 16137528
[TBL] [Abstract][Full Text] [Related]
14. Ganglioside shedding and changes in ceramide biosynthesis in human ovarian tumors.
Dyatlovitskaya EV; Andreasyan GO; Malykh YaN ; Rylova SN; Somova OG
Biochemistry (Mosc); 1997 May; 62(5):557-61. PubMed ID: 9275295
[TBL] [Abstract][Full Text] [Related]
15. Serum hepatocyte growth factor as a marker of tumor activity in head and neck squamous cell carcinoma.
Kim CH; Lee JS; Kang SO; Bae JH; Hong SP; Kahng H
Oral Oncol; 2007 Nov; 43(10):1021-5. PubMed ID: 17306605
[TBL] [Abstract][Full Text] [Related]
16. [Serum lipid-associated sialic acid (LSA) in diagnosing and monitoring ovarian cancer].
Yue K; Bian M; Zhu D; Liu W; Siu S
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Apr; 17(2):128-32. PubMed ID: 7656393
[TBL] [Abstract][Full Text] [Related]
17. Inverse correlation between serum PGE2 and T classification in head and neck cancer.
Hambek M; Baghi M; Wagenblast J; Schmitt J; Baumann H; Knecht R
Head Neck; 2007 Mar; 29(3):244-8. PubMed ID: 17123309
[TBL] [Abstract][Full Text] [Related]
18. [Behavior of serum sialic acid levels at various stages of neoplastic disease].
Adamo V; Altavilla G; Caristi N; Chillemi S; Giacobello T; Scalisi R; Palmara D
Minerva Med; 1985 Nov; 76(43):2067-70. PubMed ID: 4069416
[TBL] [Abstract][Full Text] [Related]
19. Cut-off value determination of CYFRA 21-1 for squamous cell carcinomas of the head and neck (SCCHN).
Niemann AM; Goeroegh T; Gottschlich S; Lippert BM; Werner JA
Anticancer Res; 1997; 17(4B):2859-60. PubMed ID: 9329547
[TBL] [Abstract][Full Text] [Related]
20. Gangliosides in normal human serum. Concentration, pattern and transport by lipoproteins.
Senn HJ; Orth M; Fitzke E; Wieland H; Gerok W
Eur J Biochem; 1989 May; 181(3):657-62. PubMed ID: 2731542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
